Neogenomics, Inc.
NEO
$8.75
$0.091.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.11M | -9.88M | -27.13M | -45.09M | -25.92M |
| Total Depreciation and Amortization | 16.41M | 16.40M | 16.44M | 17.26M | 17.73M |
| Total Amortization of Deferred Charges | -- | 383.00K | 381.00K | 498.00K | -- |
| Total Other Non-Cash Items | 11.76M | 10.09M | 19.42M | 33.65M | 13.11M |
| Change in Net Operating Assets | -19.20M | -15.64M | -226.00K | 14.01M | -30.24M |
| Cash from Operations | -8.14M | 1.34M | 8.88M | 20.33M | -25.33M |
| Capital Expenditure | -5.00M | -7.87M | -8.31M | -6.32M | -4.50M |
| Sale of Property, Plant, and Equipment | -- | 2.07M | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -463.00K | -5.99M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -500.00K | 8.50M | 3.00M | 8.06M |
| Cash from Investing | -5.00M | -6.31M | -277.00K | -9.31M | 3.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -201.25M | -- |
| Issuance of Common Stock | -- | 431.00K | 531.00K | -- | 949.00K |
| Repurchase of Common Stock | -- | -- | -- | -949.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -338.00K | -- | 234.00K | -234.00K | -- |
| Cash from Financing | -338.00K | 431.00K | 765.00K | -202.43M | 949.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 32.00K | 22.00K | -54.00K | -- |
| Net Change in Cash | -13.48M | -4.50M | 9.39M | -191.47M | -20.82M |